Phase i and pharmacokinetic study of the dolastatin 10 analogue TZT-1027, given on days1 and 8 of a 3-week cycle in patients with advanced solid tumors by DE JONGE, Maja J. A, VAN DER GAAST, Ate, PLANTING, André S. T, VAN DOOM, Leny, INGE BOOT, Aletta Lems, WANDERS, Jantien, SATOMI, Masahiko, VERWEIJ, Jaap

Get full text